新辅助化疗联合胃癌根治术治疗进展期胃癌的临床疗效探讨及有效性分析

2020-12-23 06:59:31司志成
中外医疗 2020年17期
关键词:新辅助化疗

司志成

[摘要] 目的 對新辅助化疗联合胃癌根治术治疗进展期胃癌的治疗效果进行研究分析。方法 该研究方便选取的对象均为该院2018年8月—2019年8月收治的46例进展期胃癌患者,将所有的进展期胃癌患者随机分为两组,每组23例,其中对照组进展期胃癌患者采用腹腔镜辅助胃癌根治术治疗,实验组进展期胃癌患者采用新辅助化疗联合腹腔镜辅助胃癌根治术进行治疗。对两组进展期胃癌患者的治疗效果、手术时间、术中出血量、术后胃肠道功能恢复时间以及进展期胃癌复发、转移率进行比较分析。结果 对比两组进展期胃癌患者的手术时间与术中出血量,实验组进展期胃癌患者均明显小于对照组患者,差异有统计学意义(P<0.05);手术治疗之后,实验组进展期胃癌患者的胃肠道功能恢复时间明显短于对照组进展期胃癌患者,差异有统计学意义(P<0.05);经过调查显示,实验组进展期胃癌患者治疗后进展期胃癌的复发率为8.70%,对照组胃癌患者胃癌复发率为13.04%,两组数据差异无统计学意义(χ2=0.224,P>0.05),而实验组胃癌患者的肿瘤转移率为0.00%,对照组胃癌患者的肿瘤转移率为17.39%,差异有统计学意义(χ2=4.381,P<0.05)。结论 对于进展期胃癌患者采用新辅助化疗联合腹腔镜辅助胃癌根治术进行治疗,具有较高的治疗效果,且手术时间较短,术中出血量较少,大幅度缩短患者的胃肠道功能恢复时间,并有效降低患者进展期胃癌的转移率,具有较高的临床意义。

[关键词] 进展期胃癌;胃癌根治术;新辅助化疗;复发率

[中图分类号] R735.2          [文献标识码] A          [文章编号] 1674-0742(2020)06(b)-0044-03

[Abstract] Objective To study and analyze the therapeutic effect of neoadjuvant chemotherapy combined with radical gastrectomy for advanced gastric cancer. Methods The subjects convenienty selected in this study were 46 patients with advanced gastric cancer who were admitted to the hospital from August 2018 to August 2019. All patients with advanced gastric cancer were randomly divided into two groups, 23 in each group, of which the control group progressed with advanced gastric cancer were treated with laparoscopic assisted radical gastrectomy. Patients with advanced gastric cancer in the experimental group were treated with neoadjuvant chemotherapy combined with laparoscopic assisted radical gastrectomy. The treatment effect, operation time, intraoperative blood loss, postoperative gastrointestinal function recovery time, and the recurrence and metastasis rate of advanced gastric cancer in two groups of patients with advanced gastric cancer were compared and analyzed. Results Comparing the operation time and intraoperative blood loss of the two groups of patients with advanced gastric cancer, the patients with advanced gastric cancer in the experimental group were significantly smaller than those in the control group, and there was a statistical significantly difference (P<0.05); The gastrointestinal function recovery time of the patients was significantly shorter than that of the patients with advanced gastric cancer in the control group, and the difference was statistical significant(P<0.05). After investigation, the recurrence rate of advanced gastric cancer in the experimental group was 8.70% after treatment. The gastric cancer recurrence rate of the gastric cancer patients in the control group was 13.04%, and there was no statistically significant difference between the two groups (χ2= 0.224, P>0.05), while the tumor metastasis rate of the gastric cancer patients in the experimental group was 0.00%, and the tumor metastasis rate of the gastric cancer patients in the control group was 17.39%, and the difference was statistically significant(χ2=4.381, P<0.05). Conclusion For patients with advanced gastric cancer, neoadjuvant chemotherapy combined with laparoscopic radical surgery for gastric cancer has a higher therapeutic effect, and the operation time is shorter, the intraoperative bleeding is less, and the recovery  time of gastrointestinal function is greatly shortened, and effectively reduce the metastasis rate of patients with advanced gastric cancer, has high clinical significance.

[Key words] Advanced gastric cancer; Radical surgery for gastric cancer; Neoadjuvant chemotherapy; Recurrence rate

作为一种我国常见的恶性肿瘤,胃癌常见于中老年男性,其发病率在恶性肿瘤中一直居于首位。胃癌的发生与生活饮食结构改变、生活压力以及幽门螺杆菌感染等因素有关,且呈现为年轻化的倾向[1-2]。在临床上,绝大多数的胃癌属于腺癌,在早期仅出现上腹不适、嗳气等非特异性症状或无明显症状,容易被忽略,因此到了发现时一般已经发展为进展期胃癌[3-4]。目前,对于进展期胃癌的治疗方法以手术治疗为主,手术切除术是唯一可能根治胃癌的治疗方法,但由于远处转移率较高,单纯依靠外科手术治疗胃癌,其治疗效果并不太理想,治疗后仍有不少转移情况发生[5-6]。……

登录APP查看全文

猜你喜欢
新辅助化疗
多西他赛、表柔比星、环磷酰胺新辅助化疗治疗晚期乳腺癌近期疗效观察
延续护理在改善乳腺癌新辅助化疗患者焦虑状态中的作用
两种新辅助化疗对乳腺癌临床治疗疗效观察
奥沙利铂+卡培他滨新辅助化疗治疗进展期胃癌疗效及毒副反应分析
新辅助化疗、单纯放疗与同步放化疗治疗宫颈癌的近期疗效对照分析
宫颈癌新辅助化疗后手术切除组织病理学变化
胃癌患者新辅助化疗中护理干预在减轻不良反应中的效果观察
超声与磁共振成像对乳腺癌新辅助化疗疗效评价的对比分析
新辅助化疗治疗60例宫颈癌的临床疗效分析
新辅助化疗对局部进展期乳腺癌保乳治疗的效果观察